Nexterone

Active Ingredient(s): Amiodarone Hydrochloride
FDA Approved: * December 24, 2008
Pharm Company: * PRISM PHARMA
Category: Irregular Heartbeat (Arrhythmia)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Nexterone Overview

Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats.[1] This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.[1] Evidence in cardiac arrest, however, is poor.[2] It can be given by mouth, intravenously, or intraosseously.[1] When used by mouth, it...

Read more Nexterone Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Amiodarone

Recent Nexterone Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Amiodarone Hydrochloride
  • Injection: 150mg/100ml (1.5mg/ml), 360mg/200ml (1.8mg/ml), 50mg/ml
  • Tablet: 100mg, 200mg, 300mg, 400mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nexterone: (2 results)

Sorted by National Drug Code
  • 43066-150 Nexterone 150 mg/100ml Intravenous Injection, Solution by Baxter Healthcare Corporation
  • 43066-360 Nexterone 360 mg/200ml Intravenous Injection, Solution by Baxter Healthcare Corporation

Other drugs which contain Amiodarone Hydrochloride or a similar ingredient: (3 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 July 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA